PBRM1 and nonpapillary renal cell carcinoma: The potential SL-associated partners for BAP1 and PBRM1, two frequent altered genes, have complemented the current VHL-predominant research and mapped a comprehensive landscape for SL interaction in ccRCC, which might help to deepen our understanding of ccRCC mutation patterns and provide an alternative strategy of personalized renal cancer treatment.